{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:07:48Z","timestamp":1791223668698,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Methionine sulfoxide (MetO) has been identified as a risk factor for vascular diseases and was considered as an important indicator of oxidative stress. However, the effects of MetO and its association with moyamoya disease (MMD) remained unclear. Therefore, we performed this study to evaluate the association between serum MetO levels and the risk of MMD and its subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We eventually included consecutive 353 MMD patients and 88 healthy controls (HCs) with complete data from September 2020 to December 2021 in our analyzes. Serum levels of MetO were quantified using liquid chromatography-mass spectrometry (LC\u2013MS) analysis. We evaluated the role of MetO in MMD using logistic regression models and confirmed by receiver-operating characteristic (ROC) curves and area under curve (AUC) values.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found that the levels of MetO were significantly higher in MMD and its subtypes than in HCs (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001 for all). After adjusting for traditional risk factors, serum MetO levels were significantly associated with the risk of MMD and its subtypes (p\u2009&amp;lt;\u20090.001 for all). We further divided the MetO levels into low and high groups, and the high MetO level was significantly associated with the risk of MMD and its subtypes (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05 for all). When MetO levels were assessed as quartiles, we found that the third (Q3) and fourth (Q4) MetO quartiles had a significantly increased risk of MMD compared with the lowest quartile (Q3, OR: 2.323, 95%CI: 1.088\u20134.959,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.029; Q4, OR: 5.559, 95%CI: 2.088\u201314.805,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this study, we found that a high level of serum MetO was associated with an increased risk of MMD and its subtypes. Our study raised a novel perspective on the pathogenesis of MMD and suggested potential therapeutic targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnins.2023.1158111","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T01:17:00Z","timestamp":1681262220000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Association between methionine sulfoxide and risk of moyamoya disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Junsheng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peicong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuming","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanren","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/strokeaha.117.018563","article-title":"Surgical Management of Moyamoya Disease","volume":"49","author":"Acker","year":"2018","journal-title":"Stroke"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.1212\/wnl.0000000000013129","article-title":"Metabolomic profiles associated with incident ischemic stroke","volume":"98","author":"Balasubramanian","year":"2022","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1073\/pnas.78.4.2155","article-title":"Enzymatic reduction of protein-bound methionine sulfoxide","volume":"78","author":"Brot","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3171\/2017.5.jns17147","article-title":"Mitochondrial abnormalities related to the dysfunction of circulating endothelial colony-forming cells in moyamoya disease","volume":"129","author":"Choi","year":"2018","journal-title":"J. Neurosurg."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1515\/revneuro-2021-0048","article-title":"Metabolomics and metabolites in ischemic stroke","volume":"33","author":"Chumachenko","year":"2022","journal-title":"Rev. Neurosci."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"18628","DOI":"10.1073\/pnas.1010171107","article-title":"Methionine sulfoxide reductase a down-regulation in human breast cancer cells results in a more aggressive phenotype","volume":"107","author":"de Luca","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/neuros\/nyy114","article-title":"Treatment of Moyamoya disease","volume":"65","author":"Deng","year":"2018","journal-title":"Neurosurgery"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11010-016-2843-6","article-title":"Methionine and methionine sulfoxide treatment induces M1\/classical macrophage polarization and modulates oxidative stress and purinergic signaling parameters","volume":"424","author":"dos Santos","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.2147\/dddt.s223218","article-title":"<p>MsrA suppresses inflammatory activation of microglia and oxidative stress to prevent demyelination via inhibition of the NOX2-MAPKs\/NF-\u03baB signaling pathway<\/p>","volume":"14","author":"Fan","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1089\/ars.2014.6022","article-title":"Methionine sulfoxide reductase a negatively controls microglia-mediated NeuroinflammationviaInhibiting ROS\/MAPKs\/NF-\u03baB signaling pathways through a catalytic antioxidant function","volume":"22","author":"Fan","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1161\/strokeaha.120.030027","article-title":"Modifiable risk factors associated with Moyamoya disease: a case-control study","volume":"51","author":"Ge","year":"2020","journal-title":"Stroke"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"953426","DOI":"10.3389\/fnut.2022.953426","article-title":"Circulating choline pathway nutrients and risk of moyamoya disease","volume":"9","author":"Ge","year":"2022","journal-title":"Front. Nutr."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"48915","DOI":"10.1074\/jbc.M105509200","article-title":"Repair of oxidized proteins. Identification of a new methionine sulfoxide reductase","volume":"276","author":"Grimaud","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.86460","article-title":"Protein methionine oxidation augments reperfusion injury in acute ischemic stroke","volume":"1","author":"Gu","year":"2016","journal-title":"JCI Insight"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1182\/blood-2015-01-544676","article-title":"Regulation of thrombosis and vascular function by protein methionine oxidation","volume":"125","author":"Gu","year":"2015","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2176\/nmc.52.245","article-title":"Spontaneous occlusion of the circle of Willis","volume":"52","year":"2012","journal-title":"Neurol. Med. Chir."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2217\/bmm-2019-0176","article-title":"Serum metabolic characteristics and biomarkers of early-stage heart failure","volume":"14","author":"Guo","year":"2020","journal-title":"Biomark. Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1080\/10715760802566541","article-title":"Protection of vascular smooth muscle cells by over-expressed methionine sulphoxide reductase a: role of intracellular localization and substrate availability","volume":"42","author":"Haenold","year":"2008","journal-title":"Free Radic. Res."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"902474","DOI":"10.3389\/fneur.2022.902474","article-title":"Hyperhomocysteinemia is a predictor for poor postoperative angiogenesis in adult patients with Moyamoya disease","volume":"13","author":"He","year":"2022","journal-title":"Front. Neurol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jacc.2017.12.006","article-title":"Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke","volume":"71","author":"Holmes","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/antiox7090122","article-title":"The functions of the mammalian methionine sulfoxide reductase system and related diseases","volume":"7","author":"Jiang","year":"2018","journal-title":"Antioxidants"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11306-018-1408-y","article-title":"Metabolomic characterization of hypertension and dyslipidemia","volume":"14","author":"Ke","year":"2018","journal-title":"Metabolomics"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5853\/jos.2015.01627","article-title":"Moyamoya disease: epidemiology, clinical features, and diagnosis","volume":"18","author":"Kim","year":"2016","journal-title":"J Stroke"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3171\/2015.4.jns142900","article-title":"Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease","volume":"124","author":"Kim","year":"2016","journal-title":"J. Neurosurg."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1161\/atvbaha.115.305857","article-title":"Deletion of methionine sulfoxide reductase a does not affect Atherothrombosis but promotes Neointimal hyperplasia and extracellular signal-regulated kinase 1\/2 signaling","volume":"35","author":"Klutho","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/s1474-4422(08)70240-0","article-title":"Moyamoya disease: current concepts and future perspectives","volume":"7","author":"Kuroda","year":"2008","journal-title":"Lancet Neurol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.freeradbiomed.2009.11.020","article-title":"Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: a new prothrombotic mechanism in diseases associated with oxidative stress","volume":"48","author":"Lancellotti","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1038\/s41598-017-05230-2","article-title":"Selenoprotein MsrB1 promotes anti-inflammatory cytokine gene expression in macrophages and controls immune response in vivo","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.abb.2004.11.012","article-title":"Cloning and characterization of antioxidant enzyme methionine sulfoxide-S-reductase from Caenorhabditis elegans","volume":"434","author":"Lee","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/1471-2407-7-172","article-title":"Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinoma","volume":"7","author":"Lei","year":"2007","journal-title":"BMC Cancer"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1152\/jn.00400.2021","article-title":"Betaine protects rats against ischemia\/reperfusion injury-induced brain damage","volume":"127","author":"Li","year":"2022","journal-title":"J. Neurophysiol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/antiox7120191","article-title":"The oxidized protein repair enzymes methionine sulfoxide reductases and their roles in protecting against oxidative stress, in ageing and in regulating protein function","volume":"7","author":"Louren\u00e7o Dos Santos","year":"2018","journal-title":"Antioxidants"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1601-183X.2011.00712.x","article-title":"A genome-wide association study for quantitative traits in schizophrenia in China","volume":"10","author":"Ma","year":"2011","journal-title":"Genes Brain Behav."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"12727","DOI":"10.1002\/anie.201605833","article-title":"A Ratiometric fluorescent probe for imaging of the activity of methionine sulfoxide reductase a in cells","volume":"55","author":"Makukhin","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1212\/WNL.0b013e318249f71f","article-title":"Homozygous c.14576G>a variant of RNF213 predicts early-onset and severe form of moyamoya disease","volume":"78","author":"Miyatake","year":"2012","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"12920","DOI":"10.1073\/pnas.231472998","article-title":"Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals","volume":"98","author":"Moskovitz","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"14071","DOI":"10.1073\/pnas.95.24.14071","article-title":"Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress","volume":"95","author":"Moskovitz","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"14167","DOI":"10.1074\/jbc.275.19.14167","article-title":"Identification and characterization of a putative active site for peptide methionine sulfoxide reductase (MsrA) and its substrate stereospecificity","volume":"275","author":"Moskovitz","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00726-021-03020-9","article-title":"Methionine sulfoxide and the methionine sulfoxide reductase system as modulators of signal transduction pathways: a review","volume":"53","author":"Moskovitz","year":"2021","journal-title":"Amino Acids"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1073\/pnas.93.5.2095","article-title":"Cloning the expression of a mammalian gene involved in the reduction of methionine sulfoxide residues in proteins","volume":"93","author":"Moskovitz","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/ham.2012.1110","article-title":"Oxidative stress in hypobaric hypoxia and influence on vessel-tone modifying mediators","volume":"14","author":"Pichler Hefti","year":"2013","journal-title":"High Alt. Med. Biol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1080\/10715762.2019.1662899","article-title":"Methionine sulfoxide reductase (Msr) dysfunction in human brain disease","volume":"53","author":"Reiterer","year":"2019","journal-title":"Free Radic. Res."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1160\/th14-07-0603","article-title":"Selenoproteins and cardiovascular stress","volume":"113","author":"Rose","year":"2015","journal-title":"Thromb. Haemost."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3390\/cells9071630","article-title":"Metabolome changes in cerebral ischemia","volume":"9","author":"Shin","year":"2020","journal-title":"Cells"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"11938","DOI":"10.1074\/jbc.REV119.007624","article-title":"Metabolite sensing and signaling in cancer","volume":"295","author":"Wang","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","article-title":"Metabolomics for investigating physiological and pathophysiological processes","volume":"99","author":"Wishart","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/jcsm.12246","article-title":"Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia","volume":"9","author":"Yang","year":"2018","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"994286","DOI":"10.3389\/fnut.2022.994286","article-title":"Association of circulating branched-chain amino acids with risk of moyamoya disease","volume":"9","author":"Zeng","year":"2022","journal-title":"Front. Nutr."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3171\/2016.2.jns152173","article-title":"RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance","volume":"126","author":"Zhang","year":"2017","journal-title":"J. Neurosurg."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s11011-022-01011-7","article-title":"Metabolomics of ischemic stroke: insights into risk prediction and mechanisms","volume":"37","author":"Zhang","year":"2022","journal-title":"Metab. Brain Dis."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1158111\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T01:17:03Z","timestamp":1681262223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1158111\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":50,"alternative-id":["10.3389\/fnins.2023.1158111"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1158111","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"article-number":"1158111"}}